A regression model for risk difference estimation in population-based case-control studies clarifies gender differences in lung cancer risk of smokers and never smokers by Kovalchik, Stephanie et al.
Kovalchik et al. BMC Medical Research Methodology 2013, 13:143
http://www.biomedcentral.com/1471-2288/13/143TECHNICAL ADVANCE Open AccessA regression model for risk difference estimation
in population-based case–control studies clarifies
gender differences in lung cancer risk of smokers
and never smokers
Stephanie A Kovalchik1*, Sara De Matteis2, Maria Teresa Landi3, Neil E Caporaso3, Ravi Varadhan4, Dario Consonni2,
Andrew W Bergen5, Hormuzd A Katki3 and Sholom Wacholder3Abstract
Background: Additive risk models are necessary for understanding the joint effects of exposures on individual
and population disease risk. Yet technical challenges have limited the consideration of additive risk models in
case–control studies.
Methods: Using a flexible risk regression model that allows additive and multiplicative components to estimate
absolute risks and risk differences, we report a new analysis of data from the population-based case–control
Environment And Genetics in Lung cancer Etiology study, conducted in Northern Italy between 2002–2005.
The analysis provides estimates of the gender-specific absolute risk (cumulative risk) for non-smoking- and
smoking-associated lung cancer, adjusted for demographic, occupational, and smoking history variables.
Results: In the multiple-variable lexpit regression, the adjusted 3-year absolute risk of lung cancer in never smokers was
4.6 per 100,000 persons higher in women than men. However, the absolute increase in 3-year risk of lung cancer for
every 10 additional pack-years smoked was less for women than men, 13.6 versus 52.9 per 100,000 persons.
Conclusions: In a Northern Italian population, the absolute risk of lung cancer among never smokers is higher in
women than men but among smokers is lower in women than men. Lexpit regression is a novel approach to
additive-multiplicative risk modeling that can contribute to clearer interpretation of population-based case–control
studies.
Keywords: Additive risk, Absolute risk, Case–control study, EAGLE, Lung cancer, Risk assessment, Sex factors,
SmokingBackground
The multiplicative model quantifies the joint effects of
exposures on the relative risk of disease and is the main-
stay of case–control analysis [1]. The contribution of the
multiplicative model to studies of disease etiology is un-
deniable. However, there are several epidemiological
questions that are more easily addressed with an additive
risk model, where exposure effects are modeled on the
absolute risk (probability) scale. In particular, additive* Correspondence: skovalch@rand.org
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reproduction in any medium, provided the orrisk models can clarify the public health significance of
exposure effects [2,3] and the interpretation of statistical
interactions [4-6]. Despite these advantages, the tech-
nical difficulties of properly constraining risk estimates
to the 0–1 range and a lack of software for constrained
additive risk regression have hindered the use of additive
risk models in case–control studies [7-9].
We recently encountered the challenge of additive risk
modeling with case–control data in an investigation of
gender differences in smoking-associated lung cancer in
the Environment and Genetics in Lung cancer Etiology
(EAGLE) Study—a population-based case–control study
conducted in Northern Italy between 2002–2005 [10]. Inal Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Projected control population by gender, age, and
regional sampling strata in the EAGLE Study
Milan Monza Brescia Pavia Varese
N Population (Number of controls)
Male
35-39 70,630 (3) 12,352 (1) 22,479 (1) 9,202 (2) 9,866 (1)
40-44 58,166 (9) 10,045 (4) 18,816 (2) 7,958 (1) 8,156 (3)
45-49 50,727 (25) 9,143 (3) 16,644 (3) 7,046 (5) 7,698 (2)
50-54 55,952 (56) 9,677 (3) 17,760 (18) 7,508 (3) 8,155 (7)
55-59 51,407 (145) 8,281 (8) 14,665 (33) 5,951 (8) 6,783 (25)
60-64 55,106 (209) 9,083 (17) 14,682 (47) 6,765 (15) 7,127 (20)
65-69 45,477 (251) 7,043 (26) 11,334 (42) 5,855 (30) 5,765 (41)
70-74 35,965 (242) 5,423 (22) 8,995 (30) 4,518 (20) 4,640 (27)
75-80 24,960 (149) 3,430 (10) 6,291 (18) 3,417 (8) 3,278 (22)
Total 448,390 (1,089) 74,477 (94) 131,666 (194) 58,220 (92) 61,468 (148)
Female
35-39 68,084 (5) 11,717 (1) 20,391 (1) 0 (0) 9,509 (2)
40-44 57,734 (2) 10,122 (1) 17,455 (1) 7,410 (4) 8,061 (1)
45-49 53,942 (13) 9,387 (4) 16,248 (7) 6,979 (3) 7,754 (6)
50-54 63,060 (27) 10,307 (1) 17,739 (3) 7,424 (7) 8,545 (2)
55-59 58,781 (61) 9,022 (2) 15,140 (7) 6,085 (5) 7,099 (6)
60-64 63,452 (43) 9,607 (5) 15,885 (8) 7,352 (4) 7,675 (3)
65-69 56,296 (73) 8,152 (5) 12,439 (9) 7,199 (7) 6,822 (4)
70-74 50,119 (63) 7,090 (3) 13,220 (7) 6,763 (4) 6,083 (4)
75-80 43,166 (62) 5,610 (1) 11,221 (10) 5,732 (3) 5,404 (9)
Total 514,634 (349) 81,014 (23) 139,738 (53) 49,212 (37) 66,952 (37)
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of the EAGLE Study, De Matteis and colleagues found
evidence of an interaction between gender and pack-
years smoked that suggested a higher susceptibility to
lung cancer in men [11,12]. The authors sought to quan-
tify the public health implications of the gender differ-
ences they found by estimating absolute risk differences
of lung cancer in men and women, adjusted for other
confounders. The risk difference estimates could theor-
etically be obtained with an additive risk model yet,
unlike methods for multiplicative modeling, reliable
methods for additive risk regression with case–control
data were not available.
To address the challenge of absolute risk estimation in
case–control studies, we present a novel regression
approach to quantify risk difference associations with
population-based case–control data using linear-expit
(lexpit) regression. Lexpit regression is an additive-
multiplicative risk model for a dichotomous outcome that
can incorporate additive and multiplicative effects of risk
factors and properly constrains risk estimates to a feasible
range. We previously showed that lexpit regression ad-
dresses the main technical challenges to additive risk ana-
lysis of binary data in cohort studies [13]. Building on this
earlier work, we extend lexpit regression to population-
based case–control studies by incorporating sampling in-
formation into the estimation procedure. After describing
the interpretation of lexpit regression and its method-
ology, we return to the question that motivated the devel-
opment of these new methods and use the lexpit model to
quantify confounder-adjusted risk difference effects of
gender for smoking- and non-smoking associated lung
cancer in the EAGLE Study.
Methods
Study participants
The EAGLE Study is a population-based case–control
study of lung cancer in a Northern Italian population.
Details of the study design have been previously de-
scribed [10]. Briefly, during 34 months of observation
between 2002–2005, 2,100 pathologically-confirmed
cases of primary lung cancer were identified from 13
hospitals in the Lombardy region. A frequency-matched
random sample of 2,120 controls was drawn from the
Lombardy census using 90 strata defined by combina-
tions of residence, age, and gender. Our analyses were
based on the 1,943 cases (92.5%) and 2,116 controls
(99.8%) who completed the study interview, and we as-
sumed that the completion of an interview was non-
informative for the risk association analyses. Table 1
shows the study’s sampling strata, the size of the control
population, and the size of the control sample in each
stratum. Approximate sampling fractions, the proba-
bility of a control subject’s selection, are equal to thecontrol sample size divided by its population size. Lexpit
analyses use the sampling information to estimate the
association of selected exposures and the 3-year
(rounded from 34 months) absolute risk of lung cancer.
Since only a small percentage of cases and controls did
not complete a study interview, population counts were
derived from the interviewed sample without adjust-
ment for interview completion.
Table 2 summarizes information on demographics,
smoking history, and environmental smoking exposure
in the cases and controls of the study sample, after ex-
cluding 157 cases and 4 controls without a complete
baseline questionnaire. Men had greater smoking expos-
ure than women overall, and in cases and controls separ-
ately. While 98% of male cases and 75% of male controls
were current or former smokers, 75% of female cases
and 43% of female controls had ever smoked. Compared
to women of the same case status, men were more likely
to have held a high-risk job [14], been exposed to to-
bacco smoke in the workplace, or to have smoked cigars,
pipes, or cigarillos (Table 2).
Table 2 Descriptive characteristics by gender for the
EAGLE study
Lung cancer cases
(n=1,943) Controls (n=2,116)
Male
(n=1,537)
Female
(n=406)
Male
(n=1,617)
Female
(n=499)
Age
35-59 301 (20) 123 (30) 371 (23) 172 (34)
60-66 428 (28) 91 (23) 469 (29) 104 (21)
67-71 362 (24) 77 (19) 366 (23) 94 (19)
72+ 446 (28) 115 (28) 411 (25) 129 (26)
P-value <0.001 <0.001
Education
None 91 (6) 21 (5) 66 (4) 24 (5)
Elementary 625 (40) 128 (32) 431 (27) 143 (29)
Middle school 424 (28) 134 (33) 456 (28) 158 (31)
High school
or more
397 (26) 123 (30) 664 (41) 174 (35)
P-value 0.005 0.0975
Ever had list A/B job
Yes 522 (34) 27 (7) 447 (28) 28 (6)
No 1,015 (66) 379 (93) 1,170 (72) 471 (94)
P-value <0.001 <0.001
ETS at the workplace
Yes 1,180 (70) 215 (54) 1,127 (70) 270 (54)
No 357 (30) 191 (46) 490 (30) 229 (46)
P-value <0.001 <0.001
Smoking variables
Ever smoked cigars, pipes, or cigarillos
Yes 267 (17) 5 (1) 309 (19) 2 (0)
No 1,270 (83) 401 (99) 1,308 (81) 497 (100)
P-value <0.001 <0.001
Smoking status
Never smoker 29 (2) 103 (25) 397 (25) 282 (57)
Former 723 (47) 116 (29) 800 (49) 110 (22)
Current 785 (51) 187 (46) 420 (26) 107 (21)
P-value <0.001 <0.001
Pack-years (Smokers only)
<5 38 (3) 31 (10) 265 (22) 97 (45)
5-19 82 (5) 56 (18) 199 (16) 50 (23)
20-39 421 (28) 124 (41) 413 (34) 49 (22)
40+ 967 (64) 92 (31) 343 (28) 21 (10)
P-value <0.001 <0.001
Years since quitting (Quitters only)
<10 337 (52) 60 (47) 158 (20) 28 (25)
10+ 386 (48) 56 (53) 642 (80) 82 (75)
P-value 0.3557 0.2059
Table 2 Descriptive characteristics by gender for the
EAGLE study (Continued)
Avg. percent inhaled (Smokers only)
25 1 (0) 5 (2) 3 (0) 1 (0)
50 62 (4) 17 (6) 36 (3) 11 (5)
75 449 (30) 113 (37) 295 (24) 53 (24)
100 995 (66) 168 (55) 886 (73) 152 (70)
P-value <0.001 0.3905
ETS = Environmental tobacco smoke.
P-values are based on a chi-squared test of gender differences by case status.
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Description
The lexpit model relates risk factors x and z to the abso-
lute risk (also called cumulative risk of disease or the
probability of disease) over a fixed time interval. Here,
both x and z can include multiple categorical or con-
tinuous variables. Denoting the absolute risk of disease
within a fixed time τ given x and z as R(x, z), the lexpit
model of cumulative risk is
R x; zð Þ ¼ β 0xþ expit γ0 þ γ 0z
  ð1Þ
a sum of additive β ' x and multiplicative exp it(γ0 + γ ' z)
components, where exp it(u) = esp(u)/(1 + exp(u)) is the
inverse-logit (expit) function, which converts the log-odds
u to the risk scale. An incidence rate can also be derived
by dividing the cumulative risk R(x,z) by the length of the
risk period τ, ⋅ R(x, z)/τ, under the assumption of constant
risk over the risk period. For case–control study designs,
the risk period length τ is typically equal to the duration of
case ascertainment. When the additive terms of lexpit are
set to zero, the model reduces to a strictly multiplicative
logistic model; when the multiplicative terms are set to
zero, the model reduces to a strictly additive binomial
linear model.
The “additive” and “multiplicative” descriptions of the
lexpit model coefficients refer to the effects of the x and
z variables on the baseline risk, or the cumulative risk of
disease in unexposed individuals, denoted as R0=expit
(γ0). According to (1), the risk in a person with x=x1 ex-
posure is β ' x1 greater than a person with x=x1-1; thus,
each β coefficient is a risk difference associated with a
unit increase in the corresponding x factor, after adjust-
ing for all remaining x and z factors.
In Equation (1), the risk in a person with z=z1 is a
multiplicative factor of the baseline risk approximately
equal to ≈ exp(γ ' z1). The exponentiated value of each γ
coefficient estimates the residual odds ratio associated
with a unit increase in the corresponding z variable, after
adjustment for the risk due to x exposures and the
Kovalchik et al. BMC Medical Research Methodology 2013, 13:143 Page 4 of 8
http://www.biomedcentral.com/1471-2288/13/143effects of remaining z. In logistic regression, coefficients
are the adjusted log-odds ratios of odds having the form
R(x, z)/(1 − R(x, z)). In lexpit regression, the log-odds ra-
tios represented by the coefficients γ involve odds of the
form (R(x, x) − β ' x)/(1 − R(x, z), where R(x, z) − β ' x is
the risk that remains after subtracting the risk due to x
exposures. Hence, we refer to the exponentiated coeffi-
cients γ of the lexpit model as “residual odds ratios”.
These residual odds ratios are directly comparable to the
odds ratio associations in a logistic regression model of z
exposures fit to the subgroup of individuals without ex-
posure to the x variables, i.e., with x = 0.
The baseline risk parameter γ0 is included in the expit
for mathematical convenience, as no constraints are re-
quired to ensure that R0=expit(γ0) is within the feasible
0–1 probability range.
Example 1: Interpretation of lexpit model coefficients
To illustrate the interpretation of the coefficients of the
lexpit model, suppose we perform a lexpit regression in
the EAGLE Study to determine the risk difference in the
3-year risk of lung cancer associated with gender, con-
trolling for the effect of smoking duration. The lexpit
model in our example is
R x1; z1ð Þ ¼ βx1 þ expit γ0 þ γz1
  ð2Þ
with univariate x1 for gender (1 = female, 0 =male) and
univariate multiplicative term z1= Years Smoked, a con-
tinuous variable. Under model (2), the 3-year risk differ-
ence between a woman and a man with equal years
smoked is R(1, z1) − (0, z1) = β Thus, β is the difference in
lung cancer risk between women and men, adjusted for
smoking.
Next we consider the independent effect of a 30-year
smoking duration. Under model (2), the residual log-
odds is lg it(R(3, 30)) = γ0 + 30γ for a man and log it(R
(1, 30) − β) = γ0 + 30γ for a woman who have smoked for
30 years. For each, the difference in the residual log-
odds compared to a never smoker (the log-odds ratio) is
30γ. Thus, γ represents increase in the odds of lung
cancer associated with an additional year’s duration of
smoking, adjusted for gender.
Estimation
Application of lexpit regression to population-based
case–control data can generate absolute risk and risk
difference estimates when an unbiased representation of
the underlying population is available. As with expansion
estimators in survey estimation [15], weighing each ob-
servation by its inverse sampling fraction, roughly, yields
an estimate of the number of individuals representative of
the “study base” [16]. To accommodate stratified sam-
pling, we suppose the study base consists of J strata. Let ijindex the ith individual within the jth stratum. The data
vector for this individual is {yij, xij, zij,wij}, where yij indi-
cates case status, xij are additive risk factors, zij are multi-
plicative risk factors, and wij is the sampling weight. For a
population-based case–control study with complete case
ascertainment and random sampling of controls within
strata, the sample weights equal 1 for all cases and the ra-
tio of the population size Nj to the number of sampled
controls nj (Nj/nj) for controls in stratum j. The use of in-
verse probabilities as sampling weights allows our meth-
odology to accommodate more complex case–control
designs (frequency matching, individual matching, etc.).
We use constrained maximum likelihood methods to
obtain estimates for the parameters of the lexpit model,
maximizing the pseudo-log-likelihood
l β; γ0; γ
  ¼ ΣjΣiwij
 yij logit R xij; zij
  þ log 1−R xij; zij
  h i
ð3Þ
If all sampling weights wij were equal to 1, as in a co-
hort design, Equation (3) would be the exact log-
likelihood of a sample of Bernoulli random variables yij,
with expected event probabilities E[yij = 1] = R(xij, zij).
The pseudo-likelihood approach extends the method
proposed by Benichou and Wacholder [17] with add-
itional constraints in the maximization to ensure that
the estimated risks for all observed risk types are
within the [0, 1] range. Estimates for Θ = (β, γ0, γ) are
therefore the solutions to the following constrained
optimization problem,
Θ^ ¼ argmaxΘ l Θð Þf g and Θ∈F
where argmaxx{f(x)} is the value of x where f(x)
achieves its maximum value and F defines the feasible
region for the parameter space,
F ¼ 0≤ β 0xþ expit γ0 þ γ 0z
 
≤ 1
 
forall x; zð Þ∈ X;Zð Þ
The quantities X and Z refer to the complete set of
risk factors in the study sample. The feasible region is
constructed from the joint distribution of (X, Z), creat-
ing a separate constraint for each unique combination of
observed x and z factors. The feasible region guarantees
that the risk estimate for each observed exposure type is
a population probability.
To impose the conditions of the feasible region, we have
adapted a constrained optimization algorithm previously
developed for cohort analyses [13]. Lexpit methods for
case–control data are similar to regression methods for
survey data. The use of sample weights makes the risk es-
timates of the lexpit model for case–control data; both
require the same design considerations for accurate
Table 3 Representation of variables included in
regression analyses of the EAGLE study
Factor Representation Values
Pack-yearsa Continuous
Female Categorical Male = 0
Female = 1
Age Continuous Years
Education Trend None = 0
Elementary = 1
Middle school = 2
High school or
more = 3
Smoked cigars, pipes, cigarillos Categorical Never Smoked = 0
Smoked = 1
ETS in the workplace Categorical No ETS = 0
ETS = 1
High-risk occupationb Categorical No occupation = 0
Occupation = 1
Average percent inhaled Trend Never smoker = 0
<25% = 1
25-49% = 2
50-74% = 3
75-100% = 4
Years since quitting Continuous Years
ETS = Environmental tobacco smoke.
a Average packs of cigarettes smoked per day x years smoked.
b List A/B high-risk occupation for lung cancer.
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use influence-based methods, a common approach for
linearized variance estimation of survey statistics [18],
to derive variances for the lexpit model’s risk estimates.
In the Additional file 1 we summarize the optimization
algorithm and the influence approach for obtaining
variance estimates for the lexpit model parameters.
Example 2: Lexpit model estimation for case–control data
To illustrate the basic estimation concept, consider a lexpit
model with a single additive effect for gender xij (1 = fe-
male, 0 =male), R(xij, 0) = βxij = exp it(γ0). Table 1 indicates
that 1,617 male controls were sampled from a population
of 774,221; 499 female controls from a population of
851,550. Treating gender as the only stratification variable,
the sampling weight for male controls was 774,221/
1,61≈479 and for female controls was 851,550/499≈1,706.
Given 1,537 total male cases and 406 total female cases of
lung cancer during the 3-year ascertainment period, the
weighted estimate for 3-year lung cancer risk in men is
expit γ^ 0
  ¼ 1; 537
1; 537þ 774;2211;617  1; 617
¼ 1; 537
1; 537þ 4; 221≈2:0=1; 000
and for women
expit γ^ 0
 þ β^ 406
406þ 851;550499  499
¼ 406
406þ 851; 550
≈0:5=1; 000
A risk difference estimate of β^ ¼ −1:5=1; 000 repre-
sents 0.15% lower risk for women than men This ex-
ample conceptualizes how the sampling probabilities of
a case–control study, when available, can be utilized to
obtain population risk estimates.
Choice of additive and multiplicative effects
The flexibility of lexpit regression in allowing estimation
of the effect of an exposure as additive, multiplicative, or
(in some cases) both, can create uncertainty about an
exposure’s true mode of effect. Although the true mode
of effect can never be known, we provide three practical
strategies to explore the functional form of a given risk-
exposure relationship: a risk-exposure scatter plot that
gives a graphical depiction between crude risk and a
continuous exposure, a testing method based on the
comparison of effects in a lexpit model with both addi-
tive and multiplicative effects of an exposure, and a
measure of goodness-of-fit. Details of each approach are
provided in the Additional file 1.Results
Lexpit regression was performed to assess the absolute
risk differences associated with gender and smoking in the
Northern Italian population represented by EAGLE partic-
ipants. Our main interest was in a model that could esti-
mate additive effects for gender, pack-years, and their
interaction, considering multiplicative effects for all remai-
ning covariates. A description of the included variables
and their codings are described in Table 3. The lexpit ana-
lysis was conducted in the R language, version 2.15 [19],
using our open-source package blm [20] (for usage exam-
ples see Additional file 2 and Additional file 3).
Estimates for the additive effects of gender showed a 4.6
per 100,000 persons higher 3-year lung cancer risk for
women than men among never smokers, adjusting for
other demographic variables (Table 4). The risk difference
effect can also be expressed as a rate by dividing by the
duration of risk, e.g. a 4.6 per 100,000 34-month risk cor-
responds to an average risk rate of 13 per 100,000 person-
years. We estimate that every 10 additional pack-years
smoked increases the 3-year lung cancer risk in male
smokers by 52.9 per 100,000 persons but by only 13.6 per
100,000 persons among women, showing a strong female-
Table 4 Lexpit regression analysis of the EAGLE Study
Factor 3-year risk
difference
(per 100,000)
95%
confidence
interval
Residual
odds
ratio
95%
confidence
interval
Female 4.6 (−1.8, 11.0)
Pack-years
(per 10 yrs)
52.9 (31.9, 73.8)
Female x
Pack-years
−39.3 (−70.1, -8.6)
Age – 60a 1.12 (1.10, 1.13)
Education – 1b 0.69 (0.60, 0.80)
High-risk
occupationc
1.01 (0.72, 1.41)
Occupational
ETS
1.54 (0.72, 1.41)
Cigars, pipes,
cigarillos
1.15 (0.86, 1.53)
Average
percent
inhaled
2.19 (1.99, 2.41)
Years since
quitting
0.94 (0.93, 0.95)
ETS = Environmental tobacco smoke.
a Centered at 60 years.
b Centered at 1, corresponding to elementary school.
c List A/B high-risk occupation for lung cancer.
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10 pack-years smoked, 95% CI=−70.1 to −8.6). After ac-
counting for the risk effects of gender and pack-years, the
residual odds ratio effects of the lexpit model found that
greater age, occupational ETS exposure, and inhalation
depth further increased lung cancer risk estimates, while
higher education and greater years since quitting de-
creased risk estimates.
As one assessment of the improvement of the fit of
the model with the use of multiplicative effects we com-
pared the weighted Hosmer-Lemeshow goodness-of-fit
statistic (Additional file 1: Section S3) among the lexpit
model, a strictly additive blm model, and a strictly mul-
tiplicative logistic model of the same variables. The
chi-squared statistic in the blm model was 20.8, the
weighted logistic model 18.2, and 15.9 with the lexpit
model, indicating an improvement in fit with the use of
the additive-multiplicative form we used.
Discussion
We have presented lexpit regression methods to estimate
adjusted absolute risk differences with population-based
case–control data. By shifting the focus from estimates of
relative risk to absolute risk, lexpit regression gives epide-
miologists a direct and reliable way to assess the public
health significance of an exposure’s effect. Moreover, lexpit
regression provides a flexible framework for handling po-
tential confounders, as variables with additive or multi-
plicative effects can be accommodated. When there isuncertainty about a variable’s mode of effect, we outlined
approaches to assess the reasonableness of each effect
type. Our open-source R package blm allows the new
methods to be implemented with the ease of standard lo-
gistic regression.
Lexpit regression is the absolute risk analog to additive-
multiplicative models for hazard rates, such as the
Cox-Aalen model [21], which have become increasingly
popular in the survival literature [22]. Each class of models
share the strength of greater flexibility in the study and
representation of the joint effects of risk factors on the
hazard rate, in the case of the Cox-Aalen model, and the
absolute risk of disease, in the case of the lexpit model.
The extension of additive-multiplicative models to abso-
lute risk estimation from a variety of study designs is sig-
nificant because of the importance of individualized risk
assessment to public health. To our knowledge, the lexpit
model is the first additive-multiplicative regression model
of risk that appropriately ensures risk estimates are within
the probability scale. Although alternative additive-
multiplicative models of risk could be developed by con-
sidering other functions for the multiplicative component
(e.g. exp), we have focused on the expit function because
of its mathematical advantages. Because of the expit func-
tion, the lexpit model will require fewer constraints than
alternative additive-multiplicative models to produce feas-
ible estimates in the 0–1 probability range.
None of more than 20 published observational studies
that have examined male–female differences in lung cancer
etiology have quantified the independent effect of gender
on the absolute risk of smoking- and non-smoking-
associated lung cancer [23-26]. Using lexpit regression, we
were able to address this important public health question.
Our findings add to the De Matteis et al. logistic regression
of the EAGLE case–control study [11] in two important
ways. First, we confirmed that gender differences in the
confounder-adjusted effect of pack-years are found on the
additive risk scale. Secondly, we found suggestive evidence
that women’s risk of lung cancer risk is higher than men’s
in never smokers but is lower than men’s in smokers. Con-
ventional unconditional logistic regression, which does not
provide estimates of absolute risk, would not identify these
findings, especially given that gender was used as a match-
ing variable in selecting controls. Thus, our novel methods
provide further insight about male-and-female differences
in lung cancer risk from previously analyzed data that has
direct public health implications.
In their commentary on the De Matteis et al. study,
Alberg and colleagues pointed to a need to further delin-
eate the clinical significance of gender differences in
lung cancer etiology [12]. Our re-analysis of the EAGLE
Study clarifies the clinical relevance of gender effects for
lung cancer risk in an Italian population by providing es-
timates of the excess lung cancer risk associated with
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suggests that some gender-related etiological factor(s)
for non-smoking-related lung cancer remains to be iden-
tified. A public health implication for the gender differ-
ences we found among smokers concerns selection
criteria for computed tomographic lung cancer screen-
ing. Current guidelines recommend screening for indi-
viduals between ages 55 and 75 years with a minimum
of 30 pack-years smoked [27]. However, in an Italian
population, we estimate that the excess lung cancer risk
for a male 30 pack-year smoker is more than 1,100 per
100,000 greater than an otherwise similar female 30
pack-year smoker. Thus, in keeping with the “equal
management for equal risk” principle [28], gender-based
risk criteria for lung cancer screening selection may be
warranted in some populations.
The implications of the EAGLE lexpit analysis for com-
puted tomographic screening guidelines exemplifies the
importance of the choice of measure of association used in
an etiological analysis for understanding the public health
significance of a risk factor’s effect. Risk differences meas-
ure a risk factor’s effect in terms of the number of excess
attributable cases in a well-defined population, an explicit
measure of the public health significance of an effect,
which can be compared across exposures and across dis-
eases. Our study provides an important example of this
comparative use of risk differences with respect to gender
effects in smoking- and non-smoking-associated lung can-
cer. Some research has suggested a higher risk of lung
cancer among women never smokers [29]. We further elu-
cidated this difference through lexpit analysis by showing
that the excess risk in women never smokers was approxi-
mately equal to the excess risk with 1 additional pack-year
smoked in men as compared to women. As the develop-
ment of public health interventions and clinical recom-
mendations become increasingly guided by individual risk
assessment, there will be a growing need for methods like
lexpit regression that can facilitate the estimation of abso-
lute risk differences from observational data.
Lexpit regression resolves several limitations of alterna-
tive strategies for estimating risk differences from case–
control studies. Using non-additive models of risk, such as
the logistic model, to estimate a marginal risk difference
[30,31] gives average in the study population, not equiva-
lent to a risk difference effect estimated here. The applica-
tion of the lexpit model to case–control data extends
previously proposed methods for absolute risk methods
requiring prospective cohorts or disease registries [32].
Further, lexpit regression advances current methods for
assessing additive interactions in case–control studies. It is
well known that multiplicative interactions sometimes dis-
appear when modeled on the additive scale [4-6,33] and
vice versa, highlighting the dependence of statistical inter-
actions on the choice of a model’s scale. The removal ofinteractions leads to more parsimonious models whose
risk associations have a clearer interpretation. The flexible
additive-multiplicative form of the lexpit can help epide-
miologists reduce multiplicative and additive statistical in-
teractions, making it easier to interpret risk effects. While
departure from additivity can be detected on the relative
risk scale using the relative excess risk due to interaction,
this metric is limited because it can only detect the direc-
tion of departure from additivity but not the magnitude of
the effect [34,35].
While lexpit regression makes the important advance
of allowing case–control studies to make inferences
about absolute risk and risk differences of exposures,
there are several challenges to its application to case–
control data. First, the period of risk for the cumulative
risk estimates of the lexpit model is determined by the
period of case ascertainment, which may generally pro-
hibit long-term risk estimates. As with other common
probability models of case–control data, the lexpit
model assumes the population risk of disease is fixed
during the period cases and controls are sampled. The
population validity of lexpit regression also requires ac-
curate sampling weights, which may be difficult to ob-
tain for studies using a so-called “secondary base” [36],
as with hospital or registry controls, for the selection of
controls. Further investigation of the availability and ac-
curacy of sampling information in case–control studies
is needed to clarify the practical limitations of using
sampling data for absolute risk estimation.
Conclusions
Additive and multiplicative models concern “two quite
different aspects of the association between risk factor
and disease” [1], p. 58. Epidemiologists have been urged
to consider both perspectives in risk association studies,
especially in the assessment of effect modification [26],
yet technical challenges have long made multiplicative
models more convenient to use. In this paper, we have
presented methods and software [27] to allow analyses
of population-based case–control studies to incorporate
these complementary perspectives into a single model
via lexpit regression. Further applications and extensions
of additive risk modeling with case–control data will
help to improve our understanding of the joint effects of
exposures on disease risk.
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